Funding round-up: Drug Farm, ORA, Nectin Therapeutics, Scandinavian Real Heart

Sweden: Scandinavian Real Heart, a developer of a total artificial heart (TAH) for implantation in patients with life-threatening heart failure, has received an initial investment from the EIC of up to €3.5m (US$3.8m) as part of Realheart’s next investment round. The investment is conditional on the investment being a co-investment with new and existing shareholders…

You must be a HMI Subscriber to view this content.

Subscribe Now »